This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jiang, W. G. Articles by Mansel, R. E. Search for Related Content PubMed PubMed Citation Articles by Jiang, W. G. Articles by Mansel, R. E.

Prognostic Value of Rho GTPases and Rho Guanine Nucleotide Dissociation Inhibitors in Human Breast Cancers

¹ University Departments of Surgery and
² Pathology, University of Wales College of Medicine, Cardiff, United Kingdom, and
³ Department of Surgery, St. George Hospital, London, United Kingdom

Purpose: Rho family members are small GTPases that are known to regulate malignant transformation and motility of cancer cells. The activities of Rhos are regulated by molecules such as guanine nucleotide dissociation inhibitors (GDIs). This study determined the levels of expression and the distribution of Rho-A, -B, -C, and -G, and Rho-6, -7, and -8, as well as Rho-GDI-ß, and Rho-GDI-, in breast cancer and assessed their prognostic value.

Experimental Design: The distribution and location of Rhos and RhoGDIs were assessed using immunohistochemical staining of frozen sections. The levels of transcripts of these molecules were determined using a real-time quantitative PCR. Levels of expression were analyzed against nodal involvement and distant metastasis, grade, and survival over a 6-year follow-up period.

Results: The levels of Rho-C, Rho-6, and Rho-G were significantly higher in breast cancer tissues (n = 120) than in background normal tissues (n = 32). However, the level of Rho-A and –B and rho-7 and -8 was found to be similar in tumor and normal tissues. Immunohistochemical staining revealed the high level of staining of Rho-C protein in tumor cells. The levels of Rho-GDI- transcripts were found to be significantly lower in tumor tissues than in normal tissues (P < 0.05 and P < 0.001, respectively). Node-positive tumors have significantly higher levels of Rho-C and Rho-G, and lower levels of Rho-GDI and Rho-GDI- transcripts, than do node-negative tumors. Significantly higher levels of Rho-C and Rho-G were seen in patients who died of breast cancer than in those who remained disease free. Patients with recurrent disease, with metastasis or who died of breast cancer, also exhibited higher levels of Rho-6 but lower levels of Rho-GDI-. Higher-grade tumors were also associated with low levels of Rho-GDI and Rho-GDI-.

Conclusions: Raised levels of Rho-C, Rho-G and Rho-6 and reduced expression of Rho-GDI and -GDI- in breast tumor tissues are correlated with the nodal involvement and metastasis. This suggests that the expression of Rhos and Rho-GDIs in breast cancer is unbalanced and that this disturbance has clinical significance in breast cancer.

This article has been cited by other articles:

				T. Ito, Y. Shimada, T. Kan, S. David, Y. Cheng, Y. Mori, R. Agarwal, B. Paun, Z. Jin, A. Olaru, et al. Pituitary Tumor-Transforming 1 Increases Cell Motility and Promotes Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma Cancer Res., May 1, 2008; 68(9): 3214 - 3224. [Abstract] [Full Text] [PDF]

				S. Hanavadi, T. A. Martin, G. Watkins, R. E. Mansel, and W. G. Jiang The Role of Growth Differentiation Factor-9 (GDF-9) and Its Analog, GDF-9b/BMP-15, in Human Breast Cancer Ann. Surg. Oncol., July 1, 2007; 14(7): 2159 - 2166. [Abstract] [Full Text] [PDF]

				S. R. Davies, G. Watkins, R. E. Mansel, and W. G. Jiang Differential Expression and Prognostic Implications of the CCN Family Members WISP-1, WISP-2, and WISP-3 in Human Breast Cancer Ann. Surg. Oncol., June 1, 2007; 14(6): 1909 - 1918. [Abstract] [Full Text] [PDF]

				Y.-F. Zhang, X.-R. Cheng, Yun Chen, Bin Shi, X.-H. Chen, D.-X. Xu, and Jin Ke Three-dimensional Nanohydroxyapatite/Chitosan Scaffolds as Potential Tissue Engineered Periodontal Tissue J Biomater Appl, April 1, 2007; 21(4): 333 - 349. [Abstract] [PDF]

				C. DerMardirossian, G. Rocklin, J.-Y. Seo, and G. M. Bokoch Phosphorylation of RhoGDI by Src Regulates Rho GTPase Binding and Cytosol-Membrane Cycling Mol. Biol. Cell, November 1, 2006; 17(11): 4760 - 4768. [Abstract] [Full Text] [PDF]

				S. Hanavadi, T. A. Martin, G. Watkins, R. E. Mansel, and W. G. Jiang Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer Ann. Surg. Oncol., June 1, 2006; 13(6): 802 - 808. [Abstract] [Full Text] [PDF]

				J. Cai, C. Parr, G. Watkins, W. G. Jiang, and M. Boulton Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin. Cancer Res., June 1, 2006; 12(11): 3510 - 3517. [Abstract] [Full Text] [PDF]

				W. G. Jiang, A. Raz, A. Douglas-Jones, and R. E. Mansel Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer J. Histochem. Cytochem., February 1, 2006; 54(2): 231 - 241. [Abstract] [Full Text] [PDF]

				J.-w. Cui, W.-h. Li, J. Wang, A.-l. Li, H.-y. Li, H.-x. Wang, K. He, W. Li, L.-h. Kang, M. Yu, et al. Proteomics-based Identification of Human Acute Leukemia Antigens That Induce Humoral Immune Response Mol. Cell. Proteomics, November 1, 2005; 4(11): 1718 - 1724. [Abstract] [Full Text] [PDF]

				W. G. Jiang, G. Davies, T. A. Martin, C. Parr, G. Watkins, M. D. Mason, K. Mokbel, and R. E. Mansel Targeting Matrilysin and Its Impact on Tumor Growth In vivo: The Potential Implications in Breast Cancer Therapy Clin. Cancer Res., August 15, 2005; 11(16): 6012 - 6019. [Abstract] [Full Text] [PDF]

				T. A. Martin, A. Goyal, G. Watkins, and W. G. Jiang Expression of the Transcription Factors Snail, Slug, and Twist and Their Clinical Significance in Human Breast Cancer Ann. Surg. Oncol., June 1, 2005; 12(6): 488 - 496. [Abstract] [Full Text] [PDF]

				E. Dransart, A. Morin, J. Cherfils, and B. Olofsson Uncoupling of Inhibitory and Shuttling Functions of Rho GDP Dissociation Inhibitors J. Biol. Chem., February 11, 2005; 280(6): 4674 - 4683. [Abstract] [Full Text] [PDF]

				W. G Jiang, G. Watkins, O. Fodstad, A. Douglas-Jones, K. Mokbel, and R. E Mansel Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 781 - 791. [Abstract] [Full Text] [PDF]